Related Experiment Video
Updated: Jun 10, 2026

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Tuberculosis in Poland in 2008]
1Zakład Epidemiologii i Organizacji Walki z Gruźlica, Instytutu Gruźlicy i Chorób Płuc, Warszawa.
Przeglad Epidemiologiczny
|August 25, 2010
Summary
Tuberculosis (TB) incidence in Poland was 21.2 per 100,000 in 2008, with higher rates in the east and among men. While decreasing annually, TB remains a significant public health concern.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Context:
- Tuberculosis (TB) remains a global health challenge, with significant regional variations in incidence and outcomes.
- Poland reported 8081 TB cases in 2008, highlighting the need for continued surveillance and control efforts.
- Understanding demographic and geographic disparities in TB is crucial for targeted interventions.
Purpose:
- To analyze the epidemiological characteristics of tuberculosis (TB) in Poland in 2008.
- To identify trends in TB incidence, case demographics, and drug resistance patterns.
- To provide data for public health strategies aimed at TB control in Poland.
Summary:
- In 2008, Poland recorded a TB incidence of 21.2/100,000, with notable east-west and male predominance.
- Pulmonary TB constituted the majority of cases (19.6/100,000), with 65.4% bacteriologically confirmed.
- Extrapulmonary TB, pediatric cases, and drug resistance (3.8%) were also documented, alongside 744 TB deaths in 2007.
Impact:
- The findings underscore the persistent burden of TB in Poland and inform targeted public health interventions.
- Data on age, sex, and geographic variations can guide resource allocation for TB prevention and treatment.
- Monitoring drug resistance is essential for effective treatment regimens and preventing treatment failures.
Related Concept Videos
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
